Catalan
nanopartícula lipídica sòlida Spanish
nanopartículas lipídicas sólidas 1
Conclusions: SLNs mapping using ICG demonstrated higher DR compared to other modalities.
2
In three patients no SLNs were found by radiotracer or blue dye.
3
The drug release from SLNs and NLCs was rather a surface-based phenomenon.
4
Analyzing the three hottest SLNs suffices to predict a patient's neck status.
5
The SLNs were identified in surgery in all but 4 cases.
6
The remaining 22 patients were negative for in-transit and regional SLNs.
7
Eight of 14 patients were found to have SLNs positive for metastatic carcinoma.
8
All SLNs were bisected along their longitudinal axis to produce two equal halves.
9
SLNs may be the initial sites of antigen presentation associated with immune responses.
10
CEUS enhancement patterns can be helpful in recognising metastatic SLNs and nodal burden.
11
SLNs and other nodes were sent separately to the pathology laboratory.
12
High diameter of LNs seems to be an exclusion criterion for SLNs mapping.
13
A total of 85 SLNs were identified,and most frequently located in obturator fossa.
14
Two SLNs were identified in the left inframesenteric para-aortic and superficial left common areas.
15
Conclusions: Melanoma will recur in approximately 9% of patients with tumor-negative SLNs.
16
At a median follow-up of 3 years, two patients showed micrometastasis in the SLNs.
